Who owns FORTE BIOSCIENCES INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Forte Biosciences with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Forte Biosciences stock

Who bought or sold FORTE BIOSCIENCES INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Federated Investors 1.8M $48M 8% Dec 2025
 View chart
Fred Alger Management 1.6M $25M 1% Sep 2025
 View chart
Henderson Group 1.4M $21M 100% Sep 2025
 View chart
OrbiMed Advisors 1.2M $18M 0% Sep 2025
 View chart
Affinity Asset Advisors 1.0M $28M 100% Dec 2025
 View chart
Tybourne Capital Management 787k $12M 0% Sep 2025
 View chart
Vanguard Group 582k $16M 3% Dec 2025
 View chart
Point72 Asset Management 487k $13M 100% Dec 2025
 View chart
Cable Car Capital 400k $11M -20% Dec 2025
 View chart
Adage Capital Partners GP 333k $5.0M 0% Sep 2025
 View chart
Woodline Partners 332k $9.1M 0% Dec 2025
 View chart
Ikarian Capital 300k $8.2M 0% Dec 2025
 View chart
FMR 244k $3.7M 100% Sep 2025
 View chart
AWM Investment Company 237k $6.5M -10% Dec 2025
 View chart
Jain Global 202k $5.5M 100% Dec 2025
 View chart
Sphera Funds Management 186k $5.1M -61% Dec 2025
 View chart
Geode Capital Management 125k $3.4M 15% Dec 2025
 View chart
Millennium Management 120k $1.8M 66% Sep 2025
 View chart
Ameriprise Financial 70k $1.0M 100% Sep 2025
 View chart
Goldman Sachs Group 68k $1.9M 100% Dec 2025
 View chart
BVF 65k $980k -89% Sep 2025
 View chart
BlackRock 65k $1.8M 27% Dec 2025
 View chart
Susquehanna International 53k $1.4M 100% Dec 2025
 View chart
State Street Corporation 51k $1.4M 33% Dec 2025
 View chart
683 Capital Management 40k $1.1M 100% Dec 2025
 View chart
Marshall Wace 36k $990k 89% Dec 2025
 View chart
Qube Research & Technologies 32k $878k 100% Dec 2025
 View chart
Northern Trust 25k $694k 9% Dec 2025
 View chart
UBS Group 25k $677k 1491% Dec 2025
 View chart
Barclays 24k $658k 2840% Dec 2025
 View chart
Envestnet Asset Management 20k $532k -16% Dec 2025
 View chart
Quest Partners 19k $513k 53% Dec 2025
 View chart
Quadrature Capital 18k $479k 100% Dec 2025
 View chart
Hudson Bay Capital Management 17k $451k 100% Dec 2025
 View chart
Landscape Capital Management 16k $431k 100% Dec 2025
 View chart
Citadel Advisors 16k $235k 100% Sep 2025
 View chart
OMERS Administration Corporation 16k $425k 100% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 16k $422k 193300% Dec 2025
 View chart
Trexquant Investment 13k $352k 100% Dec 2025
 View chart
Royal Bank of Canada 11k $169k 22% Sep 2025
 View chart
ExodusPoint Capital Management 11k $302k 100% Dec 2025
 View chart
ALPS Advisors 10k $281k 100% Dec 2025
 View chart
Persistent Asset Partners 10k $277k 100% Dec 2025
 View chart
Jane Street 8.3k $228k 100% Dec 2025
 View chart
American Century Companies 8.1k $221k 100% Dec 2025
 View chart
Simplex Trading 6.0k $164k 100% Dec 2025
 View chart
Global Retirement Partners 1.0k $27k 100% Dec 2025
 View chart
Tower Research Capital 773.00 $21k 377% Dec 2025
 View chart
Steward Partners Investment Advisory 553.00 $15k 0% Dec 2025
 View chart
Wells Fargo & Company 502.00 $14k 25000% Dec 2025
 View chart
Group One Trading 204.00 $5.6k 96% Dec 2025
 View chart
Brian McDonald 150.00 $4.1k 0% Dec 2025
 View chart
National Bank Of Canada /fi/ 76.00 $2.1k 100% Dec 2025
 View chart
Assetmark 58.00 $1.6k -28% Dec 2025
 View chart
Rockefeller Capital Management 28.00 $763.999600 100% Dec 2025
 View chart
SBI Securities 12.00 $327.000000 -8% Dec 2025
 View chart
REAP Financial Group 3.00 $81.999900 0% Dec 2025
 View chart

Who sold out of Forte Biosciences?

Fund or Company Name Date Sold Shares Held Valued At
Mink Brook Asset Management Sep 2025 81k $1.2M
Perceptive Advisors Jun 2025 68k $882k
Renaissance Technologies Sep 2025 16k $243k
Dimensional Fund Advisors Sep 2025 11k $162k
Private Trust Co Na Sep 2025 274.00 $4.1k